Characterizing fatigue associated with sunitinib and its impact on health‐related quality of life in patients with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Characterizing fatigue associated with sunitinib and its impact on health‐related quality of life in patients with metastatic renal cell carcinoma

Published:2014-03-13 Issue:12 Volume:120 Page:1871-1880
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cella David¹,Davis Mellar P.²,Négrier Sylvie³,Figlin Robert A.⁴,Michaelson M. Dror⁵,Bushmakin Andrew G.⁶,Cappelleri Joseph C.⁶,Sandin Rickard⁷,Korytowsky Beata⁸,Charbonneau Claudie⁹,Matczak Ewa¹⁰,Motzer Robert J.¹¹

Affiliation:

1. Department of Medical Social SciencesNorthwestern University Feinberg School of MedicineChicago Illinois

2. Solid Tumor OncologyCleveland ClinicCleveland Ohio

3. Centre Léon BérardLyon France

4. Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical CenterLos Angeles California

5. Genitourinary Cancer Center, Massachusetts General HospitalBoston Massachusetts

6. StatisticsPfizer IncGroton Connecticut

7. Global Health Economics and Outcomes Research Pfizer OncologySollentuna Sweden

8. Global Health Economics Outcomes Research Pfizer OncologyNew York New York

9. Global Outcomes Research, Specialty Care BU, Pfizer IncParis France

10. Pfizer OncologyNew York New York

11. Memorial Sloan‐Kettering Cancer CenterNew York New York

Funder

Pfizer

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.28660

Reference36 articles.

1. Fatigue is the Most Important Symptom for Advanced Cancer Patients Who Have Had Chemotherapy

2. Targeted Therapies for Metastatic Renal Cell Carcinoma: An Overview of Toxicity and Dosing Strategies

3. Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies

4. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic underpinnings of cancer-related fatigue;American Journal of Physiology-Endocrinology and Metabolism;2024-03-01

3. Does an Alternative Sunitinib Dosing Schedule Really Improve Survival Outcomes Over a Conventional Dosing Schedule in Patients with Metastatic Renal Cell Carcinoma? An Updated Systematic Review and Meta-Analysis;Cancers;2019-11-21

4. Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group;Future Oncology;2019-08

5. The impact of targeted therapy on healthcare resource use in patients with metastatic renal cell carcinoma: The University of Sherbrooke experience;Canadian Urological Association Journal;2018-05-14